Quantum Biopharma plans voluntary delisting of Class B shares in Canada
Quantum Biopharma said it plans to voluntarily delist its Class B shares from the Canadian Securities Exchange.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.